Learn More
Selleck Chemical LLC Iniparib (BSI-201) 10mg 160003-66-7 NSC-746045, IND-71677

Supplier: Selleck Chemical LLC S108710MG

Iniparib (BSI-201, NSC-746045, IND-71677) is a PARP1 inhibitor with demonstrated effectiveness in triple-negative breast cancer (TNBC). Phase 3. *For Research & Development use only. Product is not intended for drug, household, or human consumption.
The Fisher Scientific Encompass Program offers items which are not part of our distribution portfolio. These products typically do not have pictures or detailed descriptions. However, we are committed to improving your shopping experience. Please use the form below to provide feedback related to the content on this product.